Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment

Affiliations

• ¹ Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
• ² Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.
• ³ Division of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
• ⁴ Division of Computational Biology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
• ⁵ Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA.